BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1982901)

  • 1. Effects of neuroleptics on electrodermal activity in schizophrenic patients: a review.
    Schnur DB
    Psychopharmacology (Berl); 1990; 102(4):429-37. PubMed ID: 1982901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic effects on electrodermal responsivity to soft tones and loud noise in schizophrenia.
    Green MF; Nuechterlein KH
    Psychiatry Res; 1988 Apr; 24(1):79-86. PubMed ID: 2899332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of symptomatology and medication to electrodermal activity in schizophrenia.
    Green MF; Nuechterlein KH; Satz P
    Psychophysiology; 1989 Mar; 26(2):148-57. PubMed ID: 2567035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin-conductance orienting response in chronic schizophrenics: the role of neuroleptics.
    Spohn HE; Coyne L; Wilson JK; Hayes K
    J Abnorm Psychol; 1989 Nov; 98(4):478-86. PubMed ID: 2574203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatology and electrodermal activity as predictors of neuroleptic response in young male schizophrenic inpatients.
    Lindström EM; Ohlund LS; Lindström LH; Ohman A
    Psychiatry Res; 1992 May; 42(2):145-58. PubMed ID: 1352902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of propranolol and phenothiazines on electrodermal orienting and habituation in schizophrenia.
    Gruzelier J; Connolly J; Eves F; Hirsch S; Zaki S; Weller M; Yorkston N
    Psychol Med; 1981 Feb; 11(1):93-108. PubMed ID: 6111100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrodermal and vascular orienting response in schizophrenic patients: relationship to symptoms and medication.
    Schlenker R; Cohen R; Hubmann W; Mohr F; Wahlheim C; Watzl H; Werther P
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):152-8. PubMed ID: 7669822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the bimodality of the distribution of electrodermal orienting responses in schizophrenic patients.
    Zahn TP
    J Nerv Ment Dis; 1976 Mar; 162(3):195-9. PubMed ID: 3624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls.
    Nilsson BM; Hultman CM; Wiesel FA
    Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):339-46. PubMed ID: 16600583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What does electrodermal activity tell us about prognosis in the schizophrenia spectrum?
    Dawson ME; Schell AM
    Schizophr Res; 2002 Mar; 54(1-2):87-93. PubMed ID: 11853982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrodermal activity in schizophrenia: a quantitative study using a short interstimulus paradigm.
    Lim CL; Gordon E; Harris A; Bahramali H; Li WM; Manor B; Rennie C
    Biol Psychiatry; 1999 Jan; 45(1):127-35. PubMed ID: 9894584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent studies of psychophysiology in schizophrenia.
    Spohn HE; Patterson T
    Schizophr Bull; 1979; 5(4):581-611. PubMed ID: 42141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The electrodermal psychophysiology of schizophrenics and children at risk for schizophrenia: controversies and developments.
    Venables PH
    Schizophr Bull; 1977; 3(1):28-48. PubMed ID: 17154
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of D-or DL-propranolol and chlorpromazine on habituation of phasic electrodermal responses in schizophrenia.
    Gruzelier JH; Hirsch SR; Weller M; Murphy C
    Acta Psychiatr Scand; 1979 Sep; 60(3):241-8. PubMed ID: 495166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrodermal activity and therapeutic response to neuroleptic treatment in chronic schizophrenic in-patients.
    Schneider SJ
    Psychol Med; 1982 Aug; 12(3):607-13. PubMed ID: 7134318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrodermal reactivity in schizophrenic women with so-called basic symptoms].
    Wolfersdorf M; Straub R; Barg T; Studemund H; Ruppe A
    Fortschr Neurol Psychiatr; 1995 Sep; 63(9):363-7. PubMed ID: 7590561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrodermal responding and chlorpromazine treatment in schizophrenia.
    Yannitsi S; Liakos A; Papakostas Y
    Br J Psychiatry; 1987 Jun; 150():850-3. PubMed ID: 3651739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empathy in electrodermal responsive and nonresponsive patients with schizophrenia.
    Ikezawa S; Corbera S; Liu J; Wexler BE
    Schizophr Res; 2012 Dec; 142(1-3):71-6. PubMed ID: 23058162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covariation between two-flash threshold and skin conductance level in first-breakdown schizophrenics: relationships in drug-free patients and effects of treatment.
    Claridge G; Clark K
    Psychiatry Res; 1982 Jun; 6(3):371-80. PubMed ID: 6125983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The psychophysiology of schizophrenia (author's transl)].
    Venables PH
    Nervenarzt; 1978 Nov; 49(11):625-33. PubMed ID: 31574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.